Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.03M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.42x
$23.18Latest market snapshot
Implied fair value · at FCX's multiple
$51.06120.3% above market
2.03 AMPH EPS (TTM)×25.15x FCX P/E=$51.06
Market $23.18Implied $51.06
FCX · current priceP/E 25.15x
$72.73Latest market snapshot
Implied fair value · at AMPH's multiple
$33.0254.6% below market
2.89 FCX EPS (TTM)×11.42x AMPH P/E=$33.02
Market $72.73Implied $33.02